Drug
Dfn 15
Dfn 15: highest development phase Phase 2, developed by Dr. Reddy's. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Dr. Reddy's
Trials
| Drug | Phase | Indication |
|---|---|---|
| DFN-15 (Celecoxib Oral Solution) 62.5 mg NCT03554772 | Phase 2 | Acute Pain |
Latest
No recent events.
Follow Dfn 15 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.